LGTY

ANALYST NOTE: LGTY (Logility Supply Chain Solutions, Inc.) Date: 2026-06-13 Current Price: $14.29

1. Structural Readiness

State: Context-only Conservative Entry: — Breakout Level: — Extension: — ATR at Breakout: — ATR Current: 0.2% (Sub-threshold) Pivot Strength: — Cap Bucket: Small Sector: — Industry: —

Analysis:

2. Thesis Layer

Thesis Classification: TACTICAL, Setup-Led Secular Exposure: None Named

At this date, there is no named secular thesis attached to LGTY. The investment case is strictly tactical and setup-led. As per the StoryStocks framework, we must judge this name solely on the quality of its technical setup (which is currently undefined due to missing structural data) and its underlying business fundamentals. We do not invent a macro or thematic thesis to force a conviction score. The absence of a named secular theme means the conviction stack relies entirely on the strength of the business evidence and the eventual formation of a valid technical structure.

3. The Business

Company Overview: Logility Supply Chain Solutions, Inc. (operating under the broader umbrella of American Software, Inc. as of the 2026 profile data) is a global provider of enterprise business application software. The company operates through two primary divisions: Supply Chain Management (SCM) and an "Other" segment.

Business Model & Operations:

• SCM Division: Offers a unified platform managing eight key functions: product lifecycle, demand forecasting, inventory optimization, supply planning, network configuration, order fulfillment, supplier relationship management, and strategic scenario analysis.
• "Other" Segment: Delivers software and services for procurement, materials handling, client order processing, financial administration, e-commerce, and traditional manufacturing operations.
• Distribution: Solutions are distributed via direct sales forces and indirect partner channels.
• Customer Base: Serves diverse industries including apparel, soft goods, food and beverage, FMCG, consumer durables, wholesale distribution, retail, and process/chemical manufacturing.

Fundamental Evidence (Source Date: 2024-08-23): Management provided specific data points regarding the company's trajectory leading into the 2026 period:

• Backlog Growth: "Our remaining performance obligations, we exited this quarter $125 million, and that's a 13% increase from last year at this time" (E1).
• Pipeline Drivers: "Our late-stage pipeline has continued to expand due to the delays we've experienced over the past 18 to 24 months and new interest that is being stimulated by the calendar year 2025 budgeting cycle" (E2).
• Product Traction: "Our AI first approach to supply chain planning continues to resonate with new and existing clients" (E3). Specifically, "DAI+ featured prominently among our new client wins this quarter" (E4).
• Margin Performance: "The strongest gross margin performance we've seen in over a year, which, combined with disciplined expense management, drove our adjusted EBITDA margin up to nearly 18%" (E6).

Financial Context (Source Date: 2026-06-12):

• Forward Consensus: The financial spine indicates a Forward consensus EPS (FY1) of $0.38425 (E14).

4. Archetype and Conviction

Archetype Candidate: Quality Compounder Fit Analysis: The name aligns with the Quality Compounder archetype based on the evidence of expanding performance obligations, margin expansion, and the successful integration of AI-driven solutions (DAI+) into the product suite. The 13% year-over-year increase in remaining performance obligations and the 18% adjusted EBITDA margin suggest a business model that is scaling efficiently while maintaining pricing power.

Conviction Stack:

• Thesis Strength: Low (No named secular thesis; purely tactical).
• Evidence Quality: Moderate to High (Strong earnings transcript data from 2024 regarding backlog and margins; 2026 profile confirms operational scope).
• Setup Readiness: Not Actionable. The setup is currently in a "context-only" state. The sub-threshold ATR (0.2%) suggests a lack of immediate volatility required for a breakout, but without the price structure, this is merely a data point.
• Rerating Potential: Dependent on the confirmation of the "Quality Compounder" fundamentals translating into a technical breakout. The forward EPS of $0.38425 provides a baseline, but the multiple expansion depends on the setup firing.

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• Fundamental Continuation: Continued growth in remaining performance obligations and maintenance of the ~18% EBITDA margin in subsequent quarters.
• AI Adoption: Further evidence of DAI+ or AI-first solutions driving new client wins beyond the 2024 baseline.

What Would Invalidate the Case:

• Fundamental Deterioration: A contraction in remaining performance obligations or a significant drop in EBITDA margins below the 18% level.
• Pipeline Stagnation: A halt in the expansion of the late-stage pipeline, suggesting the "2025 budgeting cycle" tailwinds have exhausted.

Gaps in Evidence Base:

• Recent Financials: The earnings transcript evidence is dated 2024-08-23. While the company profile and financial spine are dated 2026-06-12, there is no specific earnings transcript or management guidance from the 2025 or 2026 fiscal periods to confirm if the 2024 trends (13% backlog growth, 18% margin) have persisted or accelerated.
• Sector/Industry Classification: The specific sector and industry labels are missing from the current data snapshot.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: low Key evidence: 1) 13% YoY increase in remaining performance obligations ($125M) recorded in 2024; 2) Adjusted EBITDA margin expansion to nearly 18% driven by disciplined expense management; 3) Strong traction for AI-first approach and DAI+ solution in new client wins. Key risks: 1) Critical missing structural setup data prevents technical classification or entry; 2) Sub-threshold ATR (0.2%) indicates low volatility and lack of immediate momentum; 3) No named secular thesis to provide conviction weighting beyond tactical setup. Sizing hint: Position size should be zero until structural setup is defined; current data does not support allocation. Expected path: Management expectations of continued pipeline expansion and margin stability should persist if the 2024 trends hold, but the stock requires a technical breakout to become actionable. Expected horizon: Indefinite until structural setup forms; dependent on market volatility increasing to exceed ATR thresholds.